Skip to main content

Circulating Endothelial Cells: Characteristics and Clinical Relevance

  • Chapter
  • First Online:
Atlas of Liquid Biopsy

Abstract

Here, in this chapter, we intend to analyze literature on endothelial cells and these precursors, which are an organically special element, with a large number of physiological functions, such as homeostasis, endocrine, exocrine, structural and others, but also involved in clinical set. The knowledge about endothelial cells may encompass angiogenic inhibition therapy, and may be a promising anticancer treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Altorki NK, Markowitz GJ, Gao D, Port JL, Saxena A, Stiles B, McGraw T, Mittal V. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2019;19:9–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Anastasiou D. Tumour microenvironment factors shaping the cancer metabolism landscape. Br J Cancer. 2017;116:277–86.

    Article  CAS  PubMed  Google Scholar 

  3. Angara K, Borin TF, Arbab AS. Vascular mimicry: a novel neovascularization mechanism driving anti-Angiogenic therapy (AAT) resistance in glioblastoma. Transl Oncol. 2017;10:650–60.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–6.

    Article  CAS  PubMed  Google Scholar 

  5. Asahara T, Kawamoto A, Masuda H. Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells. 2011;29:1650–5.

    Article  CAS  PubMed  Google Scholar 

  6. Balaji S, King A, Crombleholme TM, Keswani SG. The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing. Adv Wound Care. 2013;2:283–95.

    Article  Google Scholar 

  7. Bertolini F, Shaked Y, Mancuso P, Kerbel RS. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer. 2006;6:835–45.

    Article  CAS  PubMed  Google Scholar 

  8. Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bregenzer ME, Horst EN, Mehta P, Novak CM, Raghavan S, Snyder CS, Mehta G. Integrated cancer tissue engineering models for precision medicine. PLoS One. 2019;14:e0216564.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Casanovas O, Pons-Cursach R. Mechanisms of anti-angiogenic therapy. In: Marmé D, editor. Tumor angiogenesis. Springer International Publishing: Cham; 2017. p. 1–25.

    Google Scholar 

  11. Castro PR, Barbosa AS, Pereira JM, Ranfley H, Felipetto M, Gonçalves CAX, Paiva IR, Berg BB, Barcelos LS. Cellular and molecular heterogeneity associated with vessel formation processes. Biomed Res Int. 2018;2018:1–32.

    Article  CAS  Google Scholar 

  12. Chen K-C, Lee T-P, Pan Y-C, Chiang C-L, Chen C-L, Yang Y-H, Chiang B-L, Lee H, Wo AM. Detection of circulating endothelial cells via a microfluidic disk. Clin Chem. 2011;57:586–92.

    Article  CAS  PubMed  Google Scholar 

  13. Chew V, Toh HC, Abastado J-P. Immune microenvironment in tumor progression: characteristics and challenges for therapy. J Oncol. 2012;2012:608406.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Cima I, Kong SL, Sengupta D, Tan IB, Phyo WM, Lee D, Hu M, Iliescu C, Alexander I, Goh WL, et al. Tumor-derived circulating endothelial cell clusters in colorectal cancer. Sci Transl Med. 2016;8:345ra89.

    Article  PubMed  CAS  Google Scholar 

  15. Danova M, Comolli G, Manzoni M, Torchio M, Mazzini G. Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: a critical evaluation. Mol Clin Oncol. 2016;4:909–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Deaton A, Cartwright N. Understanding and misunderstanding randomized controlled trials. Soc Sci Med. 2018;210:2–21.

    Article  PubMed  Google Scholar 

  17. Garmy-Susini B, Varner JA. Circulating endothelial progenitor cells. Br J Cancer. 2005;93:855–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Goon PKY, Lip GYH, Stonelake PS, Blann AD. Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index. Neoplasia N Y N. 2009;11:771–9.

    Article  CAS  Google Scholar 

  19. Hida K, Maishi N, Annan DA, Hida Y. Contribution of tumor endothelial cells in cancer progression. Int J Mol Sci. 2018;19:1272.

    Article  PubMed Central  CAS  Google Scholar 

  20. Koustas E, Sarantis P, Kyriakopoulou G, Papavassiliou AG, Karamouzis MV. The interplay of autophagy and tumor microenvironment in colorectal cancer—ways of enhancing immunotherapy action. Cancers. 2019;11:533.

    Article  CAS  PubMed Central  Google Scholar 

  21. Lee SH, Jeong D, Han Y-S, Baek MJ. Pivotal role of vascular endothelial growth factor pathway in tumor angiogenesis. Ann Surg Treat Res. 2015;89:1–8.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Li C, Wu Q, Liu B, Yao Y, Chen Y, Zhang H, Wang C, Cao J, Ge S. Detection and validation of circulating endothelial cells, a blood-based diagnostic marker of acute myocardial infarction. PLoS One. 2013;8:e58478.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Li Y-L, Zhao H, Ren X-B. Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward? Cancer Biol Med. 2016;13:206–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Li Y, Liu J, Zhao Z, Wen L, Li H, Ren J, Liu H. Correlation between circulating endothelial progenitor cells and serum carcinoembryonic antigen level in colorectal cancer. Acta Biochim Biophys Sin. 2018;50:307–12.

    Article  CAS  PubMed  Google Scholar 

  25. Li B, Nie Z, Zhang D, Wu J, Peng B, Guo X, Shi Y, Cai X, Xu L, Cao F. Roles of circulating endothelial progenitor cells and endothelial cells in gastric carcinoma. Oncol Lett. 2018;15:324–30.

    PubMed  Google Scholar 

  26. Löffek S. Transforming of the tumor microenvironment: implications for TGF- β inhibition in the context of immune-checkpoint therapy. J Oncol. 2018;2018:1–9.

    Article  CAS  Google Scholar 

  27. Maeda R, Ishii G, Ito M, Hishida T, Yoshida J, Nishimura M, Haga H, Nagai K, Ochiai A. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. J Thorac Oncol. 2012;7:503–11.

    Article  CAS  PubMed  Google Scholar 

  28. Maj E, Papiernik D, Wietrzyk J. Antiangiogenic cancer treatment: the great discovery and greater complexity (review). Int J Oncol. 2016;49:1773–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Marçola M, Rodrigues CE. Endothelial progenitor cells in tumor angiogenesis: another brick in the wall. Stem Cells Int. 2015;2015:832649.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Nakajima K, Ino Y, Iwasaki T, Hiraoka N. Abstract A094: characterization of pancreatic cancer endothelial cells: approach to enhance immune cell infiltration for immunotherapy. In: Tackling the tumor microenvironment: beyond T-cells: American Association for Cancer Research; 2019. p. A094.

    Google Scholar 

  31. Norton K-A, Popel AS. Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis. Sci Rep. 2016;6:36992.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Peltanova B, Raudenska M, Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer. 2019;18:63.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC, Antin JH, Myerson D, Hamilton SR, Vogelstein B, et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med. 2005;11:261–2.

    Article  CAS  PubMed  Google Scholar 

  34. Purhonen S, Palm J, Rossi D, Kaskenpaa N, Rajantie I, Yla-Herttuala S, Alitalo K, Weissman IL, Salven P. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc Natl Acad Sci. 2008;105:6620–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Roma-Rodrigues C, Mendes R, Baptista P, Fernandes A. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci. 2019;20:840.

    Article  CAS  PubMed Central  Google Scholar 

  36. Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer. 2011;2:1097–105.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Sullivan MR, Danai LV, Lewis CA, Chan SH, Gui DY, Kunchok T, Dennstedt EA, Vander Heiden MG, Muir A. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife. 2019;8:e44235.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Tanaka S, Ueno T, Ishiguro H, Morita S, Toi M. The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients. NPJ Precis Oncol. 2017;1:6.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Thomas D, Radhakrishnan P. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis. Mol Cancer. 2019;18:14.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Velazquez OC. Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing. J Vasc Surg. 2007;45(Suppl A):A39–47.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Walker C, Mojares E, Del Río Hernández A. Role of extracellular matrix in development and cancer progression. Int J Mol Sci. 2018;19:3028.

    Article  PubMed Central  CAS  Google Scholar 

  42. Yao X, Ping Y, Liu Y, Chen K, Yoshimura T, Liu M, Gong W, Chen C, Niu Q, Guo D, et al. Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in Vasculogenic mimicry formation, neovascularization and tumor initiation by glioma stem-like cells. PLoS One. 2013;8:e57188.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Yehya AHS, Asif M, Petersen SH, Subramaniam AV, Kono K, Majid AMSA, Oon CE. Angiogenesis: managing the culprits behind tumorigenesis and metastasis. Medicina (Kaunas, Lithuania). 2018;54:8.

    Article  Google Scholar 

  44. Yu Y, Cui J. Present and future of cancer immunotherapy: a tumor microenvironmental perspective (review). Oncol Lett. 2018;16:4105–13.

    PubMed  PubMed Central  Google Scholar 

  45. Zhang Y-F, Jiang S-H, Hu L-P, Huang P-Q, Wang X, Li J, Zhang X-L, Nie H-Z, Zhang Z-G. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy. Chin Clin Oncol. 2019;8:18.

    Article  PubMed  Google Scholar 

  46. Zhou F, Zhou Y, Yang M, Wen J, Dong J, Tan W. Optimized multiparametric flow cytometric analysis of circulating endothelial cells and their subpopulations in peripheral blood of patients with solid tumors: a technical analysis. Cancer Manag Res. 2018;10:447–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Zuazo-Gaztelu I, Casanovas O. Unraveling the role of angiogenesis in cancer ecosystems. Front Oncol. 2018;8:248.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Gabriel Rodríguez Tarazona .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tarazona, J.G.R., Chinen, L.T.D. (2021). Circulating Endothelial Cells: Characteristics and Clinical Relevance. In: Chinen, L.T.D. (eds) Atlas of Liquid Biopsy. Springer, Cham. https://doi.org/10.1007/978-3-030-69879-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-69879-9_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-69878-2

  • Online ISBN: 978-3-030-69879-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics